RT Journal Article
SR Electronic
T1 Immunotherapy rechallenge of patients with advanced NSCLC progression after sequential treatment with third-generation EGFR-TKI and immunotherapy
JF Cancer Biology & Medicine
JO Cancer Biology & Medicine
FD China Anti-Cancer Association
SP 1544
OP 1552
DO 10.20892/j.issn.2095-3941.2025.0393
VO 22
IS 12
A1 Hu, Shuyi
A1 Wu, Zipeng
A1 Dai, Yingying
A1 Shi, Xinhong
A1 Hu, Qin
A1 Liu, Caolu
A1 Zhu, Yifei
A1 Yu, Ruofan
A1 Li, Jingwen
A1 Liu, Ying
A1 Liu, Tianyi
A1 Lu, Lin
A1 Yao, Chengyun
A1 Shen, Bo
A1 Shi, Meiqi
A1 Chen, Cheng
A1 Wang, Xiaohua
A1 Zhou, Guoren
YR 2025
UL http://www.cancerbiomed.org/content/22/12/1544.abstract
AB